Cargando…
Mesenchymal stromal cells in the development and therapy of bronchopulmonary dysplasia
Bronchopulmonary dysplasia (BPD), the chronic lung disease of prematurity, remains a major healthcare burden. Despite great progresses in perinatal medicine over the past decades, no cure for BPD has been found. The complex pathophysiology of the disease further hampers the development of effective...
Autores principales: | Möbius, Marius A., Rüdiger, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854850/ https://www.ncbi.nlm.nih.gov/pubmed/27142639 http://dx.doi.org/10.1186/s40348-016-0046-6 |
Ejemplares similares
-
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
por: Shahzad, Tayyab, et al.
Publicado: (2016) -
Mesenchymal stromal/stem cells and bronchopulmonary dysplasia
por: Zhang, Shuqing, et al.
Publicado: (2023) -
Stem Cells and Their Mediators – Next Generation Therapy for Bronchopulmonary Dysplasia
por: Möbius, Marius A., et al.
Publicado: (2015) -
MicroRNA in late lung development and bronchopulmonary dysplasia: the need to demonstrate causality
por: Nardiello, Claudio, et al.
Publicado: (2016) -
Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta‐Analysis of Preclinical Studies
por: Augustine, Sajit, et al.
Publicado: (2017)